2018
DOI: 10.1590/1806-9282.64.11.1017
|View full text |Cite
|
Sign up to set email alerts
|

Polycystic ovarian syndrome: rs1799752 polymorphism of ACE gene

Abstract: SUMMARY PURPOSE: To investigate the contribution of the deletion polymorphism and insertion (rs1799752) of the angiotensin converting enzyme (ACE) gene in the aetiology of Polycystic Ovarian Syndrome (PCOS). METHODOLOGY: 97 women diagnosed with PCOS who received care at the Gynaecology and Obstetrics clinic of the Hospital das Clínicas of UFTM, participated in this study. The control group consisted of 94 women. All participants were submitted to the collection of 10 mL of whole blood and the genomic DNA was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“… 11 , 12 , 13 , 14 , 15 , 16 RAS includes Angiotensin‐Converting Enzyme ( ACE ), the key effector peptide of RAS, converts angiotensin‐I to angiotensin‐II and splits bradykinin into inactive fragments. 11 The alteration of ACE enzyme activity was associated with the development of many diseases such as COVID, 17 , 18 hypertension, and cardiovascular diseases (CVDs), 19 , 20 renal pathology, 21 Alzheimer disease, 22 , 23 polycystic ovarian syndrome, 24 and cancers. 25…”
Section: Introductionmentioning
confidence: 99%
“… 11 , 12 , 13 , 14 , 15 , 16 RAS includes Angiotensin‐Converting Enzyme ( ACE ), the key effector peptide of RAS, converts angiotensin‐I to angiotensin‐II and splits bradykinin into inactive fragments. 11 The alteration of ACE enzyme activity was associated with the development of many diseases such as COVID, 17 , 18 hypertension, and cardiovascular diseases (CVDs), 19 , 20 renal pathology, 21 Alzheimer disease, 22 , 23 polycystic ovarian syndrome, 24 and cancers. 25…”
Section: Introductionmentioning
confidence: 99%
“…After reviewing all of the publications, duplicated papers, reviews, abstracts, and studies about other SNPs were removed. Then 13 eligible studies with 3,212 PCOS cases and 2,314 controls were included in the following analysis [11,12,[15][16][17][18][19][20][21][22][23][24][25]. The flow of retrieval is shown in Figure 1.…”
Section: Essential Characteristics Of Eligible Studiesmentioning
confidence: 99%
“…All of the PCOS cases were diagnosed according to the Rotterdam criteria, and the controls were the healthy females without any manifestation or diagnosis of PCOS. The participants in six studies were Asians from India, China, and Pakistan [11,18,[22][23][24][25], while the other seven were Caucasians from Poland, Brazil, and Turkey [12,[15][16][17][19][20][21]. Only 6 studies had data for T, insulin, HOMA-IR, or LH/FSH.…”
Section: Essential Characteristics Of Eligible Studiesmentioning
confidence: 99%